Increased Birth Defect Risks in Two FDA-Approved Epilepsy Medications
avatar
phylisfeinerjohnson posted:
Two epilepsy drugs — Lamictal and Keppra — which are currently listed in category C may be dangerous to a fetus and should be listed in category D, according to new data. The difference between the categories is that D shows evidence of risk, but the benefits outweigh the risks. While category C is indicated for drugs that have shown to be harmful in animal studies...

http://central-pennsylvania.injuryboard.com/fda-and-prescription-drugs/increased-birth-defect-risks-in-two-fdaapproved-epilepsy-medications.aspx?googleid=295210
Reply